ICH facilitates global harmonisation by promoting a uniform set of regulatory standards across different countries. Through its guidelines, ICH provides a common framework that is recognized by regulatory authorities worldwide, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan. This harmonisation helps reduce duplication of efforts and streamline the drug approval process, benefiting both the industry and patients.
